Quarterly Transactions Made in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN). The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 1,941,031 | 382,512 | 2,323,543 | 917,883 | 203,513 | 1,121,396 | 1,202,147 | |
Q4 2021 | 4,274,381 | 18,384,379 | 22,658,760 | 90,688 | 8,642 | 99,330 | 22,559,430 | |
Q1 2022 | 2,492,262 | 338,218 | 2,830,480 | 606,895 | 710,788 | 1,317,683 | 1,512,797 | |
Q2 2022 | 15,558,453 | 3,156,212 | 18,714,665 | 715,072 | 1,865,437 | 2,580,509 | 16,134,156 | |
Q3 2022 | 6,591,202 | 2,531,212 | 9,122,414 | 6,786,013 | 0 | 6,786,013 | 2,336,401 | |
Q4 2022 | 3,404,847 | 2,801,301 | 6,206,148 | 5,585,773 | 0 | 5,585,773 | 620,375 | |
Q1 2023 | 7,073,937 | 2,473,067 | 9,547,004 | 5,466,952 | 461,631 | 5,928,583 | 3,618,421 | |
Q2 2023 | 13,007,367 | 8,848,123 | 21,855,490 | 2,170,474 | 0 | 2,170,474 | 19,685,016 | |
Q3 2023 | 5,297,046 | 1,391,624 | 6,688,670 | 6,175,139 | 0 | 6,175,139 | 513,531 | |
Q4 2023 | 7,743,340 | 12,089,960 | 19,833,300 | 7,675,449 | 2,491,561 | 10,167,010 | 9,666,290 | |
Q1 2024 | 2,725,579 | 2,259,368 | 4,984,947 | 6,819,230 | 0 | 6,819,230 | -1,834,283 | |
Q2 2024 | 6,074,712 | 11,385,879 | 17,460,591 | 4,373,458 | 0 | 4,373,458 | 13,087,133 | |
Q3 2024 | 13,438,104 | 7,974,006 | 21,412,110 | 2,173,143 | 0 | 2,173,143 | 19,238,967 |